Page last updated: 2024-08-26

vinpocetine and B-Cell Chronic Lymphocytic Leukemia

vinpocetine has been researched along with B-Cell Chronic Lymphocytic Leukemia in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kim, DH; Lerner, A1

Other Studies

1 other study(ies) available for vinpocetine and B-Cell Chronic Lymphocytic Leukemia

ArticleYear
Type 4 cyclic adenosine monophosphate phosphodiesterase as a therapeutic target in chronic lymphocytic leukemia.
    Blood, 1998, Oct-01, Volume: 92, Issue:7

    Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Antibodies, Anti-Idiotypic; Antigens, CD19; Antineoplastic Agents; Apoptosis; B-Lymphocytes; Bucladesine; Calcium; Calmodulin; Cells, Cultured; Colforsin; Cyclic AMP; DNA, Complementary; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Humans; Interleukin-2; Isoenzymes; Leukemia, Lymphocytic, Chronic, B-Cell; Leukocytes, Mononuclear; Phosphodiesterase Inhibitors; Polymerase Chain Reaction; Pyrrolidinones; RNA, Messenger; Rolipram; Tumor Cells, Cultured; Tumor Stem Cell Assay; Vinca Alkaloids

1998